MGC BioPQQ
MGC BioPQQ, a subsidiary of the MGC Group, is a leading player in the biotechnology industry, headquartered in Japan. Established in 2015, the company has rapidly gained recognition for its innovative approach to health and wellness, particularly in the development of bioactive compounds. Specialising in the production of Pyrroloquinoline Quinone (PQQ), MGC BioPQQ offers unique products that support cellular energy and overall vitality. Their commitment to quality and scientific research has positioned them as a trusted name in the market, catering to both domestic and international clients. With a focus on sustainability and cutting-edge technology, MGC BioPQQ continues to make significant strides in the health supplement sector, contributing to advancements in nutritional science and enhancing consumer well-being.
DitchCarbon Score
How does MGC BioPQQ's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MGC BioPQQ's score of 39 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MGC BioPQQ's reported carbon emissions
In 2023, MGC BioPQQ reported total carbon emissions of approximately 10,000,000,000 kg CO2e, with emissions distributed across various scopes: 715,000,000 kg CO2e (Scope 1), 682,000,000 kg CO2e (Scope 2), and 9,265,000,000 kg CO2e (Scope 3). The company has set ambitious long-term climate commitments, aiming for a zero-carbon society by 2050. This initiative encompasses both Scope 1 and Scope 2 emissions, reflecting a comprehensive approach to reducing their carbon footprint. In comparison, emissions in 2022 were about 9,374,000,000 kg CO2e for Scope 3, 743,000,000 kg CO2e for Scope 1, and 583,000,000 kg CO2e for Scope 2. The data indicates a slight decrease in Scope 1 emissions from 2022 to 2023, while Scope 3 emissions have remained significantly high. MGC BioPQQ's commitment to energy transition and carbon neutrality aligns with industry standards, showcasing their dedication to sustainability and climate action. The company is actively working towards these goals, with a focus on reducing emissions across all scopes as part of their long-term strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 749,010,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 222,812,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 7,134,439,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MGC BioPQQ is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
